← Back to Search
Microparticles And Polymers For The Mucosal Delivery Of Vaccines.
Published 1998 · Medicine
Download PDFAnalyze on Scholarcy
Because microparticles are taken up across the gastrointestinal tract following oral administration, they may be exploited for the oral delivery of labile compounds. For example, microparticles have been used for the oral delivery of peptide and protein drugs, and have resulted in improvements in bioavailability. In addition, microparticles have also been exploited for the oral delivery of vaccines, inducing potent immune responses and protective immunity. However, the extent of uptake of microparticles across the gut may limit their potential for oral delivery. Therefore, intranasal immunization is an attractive approach for the induction of mucosal immunity. Microparticles have also been used for the delivery of vaccines to the respiratory tract. In addition to the use of small microparticles to target antigens to mucosal lymphoid tissues, polymeric coatings may also be employed simply to protect antigens against degradation during transit in the gut. Hence, oral delivery using polymers is not necessarily dependent on the uptake of the delivery system across the gut. Recent studies have indicated that a number of polymeric delivery systems possess significant potential for the development of mucosally administered vaccines. However, further work is needed in a number of areas, including the stabilization of antigens within the polymeric delivery systems.
This paper references
Microsphere absorption by the nasal mucosa of the rat.
H. O. Alpar (1994)
Intestinal Uptake of Fluorescent Microspheres in Young and Aged Mice 1
M. Lefevre (1989)
Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.
S. Challacombe (1992)
Effect of animal age on the uptake of large particulates across the epithelium of the rat small intestine.
L. Simon (1994)
Intestinal translocation of particulates — implications for drug and antigen delivery
D. O'hagan (1990)
THE INTESTINAL UPTAKE OF PARTICLES AND THE IMPLICATIONS FOR DRUG AND ANTIGEN DELIVERY
O'Hagan Dt (1996)
Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines.
The Transfer of Polystyrene Microspheres from the Gastrointestinal Tract to the Circulation after Oral Administration in the Rat
J. Eyles (1995)
Incorporation of the reovirus M cell attachment protein into small unilamellar vesicles: incorporation efficiency and binding capability to L929 cells in vitro.
W. Rubas (1990)
IgA antibody produced by local presentation of antigen in orally primed rats.
D. S. Cox (1984)
Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches
J. Eldridge (1990)
Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.
A. Moore (1995)
Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles.
A. M. Hillery (1994)
Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (ISCOM).
M. Thapar (1991)
Humoral immunity to aerosolized staphylococcal enterotoxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres.
J. Tseng (1995)
Poly(butyl-2-cyanoacrylate) particles as adjuvants for oral immunization.
D. O'hagan (1989)
Pharmacokinetic evaluation of indomethacin nanocapsules.
V. Andrieu (1989)
The potential use of poly(methacrylic acid) hydrogels for oral administration of drugs and vaccines to ruminants
T. Bowersock (1994)
Immunoglobulin levels and antibody to Candida albicans in human cervicovaginal secretions.
R. Waldman (1972)
Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection.
D. I. Jones (1996)
56 – Endocrine Regulation of Mucosal Immunity: Effect of Sex Hormones and Cytokines on the Afferent and Efferent Arms of the Immune System in the Female Reproductive Tract
C. Wira (1994)
Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant.
A. Di Tommaso (1996)
SALIVARY ANTIBODIES AND SYSTEMIC TOLERANCE IN MICE AFTER ORAL IMMUNIZATION WITH BACTERIAL ANTIGENS *
S. Challacombe (1983)
Formation of agglutinating and reaginic antibodies in rabbits following oral administration of soluble and particulate antigens.
O. Strannegård (1969)
Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses
Preparation and characterization of a biodegradable microparticle antigen/cytokine delivery system.
D. Rafferty (1996)
The number and distribution of lymphoid follicles in the human large intestine.
J. Langman (1986)
Lymphoglandular complexes of the colon: structure and distribution
A. O’Leary (1986)
Activation patterns of murine B cells after oral administration of an encapsulated soluble antigen.
S. Jain (1996)
Oral immunization with influenza virus in biodegradable microspheres.
Z. Moldoveanu (1993)
Cholera toxin B subunit (CTB) entrapped in microparticles shows comparable immunogenicity to CTB mixed with whole cholera toxin following oral immunization
D. O'hagan (1995)
Orally administered microencapsulated reovirus can bypass suckled, neutralizing maternal antibody that inhibits active immunization of neonates.
S. Periwal (1997)
In vivo biocompatibility studies of medisorb® 65/35 D,L-lactide/glycolide copolymer microspheres
Kazuhiro Yamaguchi (1993)
Oral vaccination with alginate microsphere systems
T. Bowersock (1996)
Uptake and translocation of fluorescent latex particles by rabbit Peyer's patch follicle epithelium: a quantitative model for M cell uptake.
J. Pappo (1989)
A study of particulate intestinal absorption and hepatocellular uptake. Use of polystyrene latex particles.
E. Sanders (1961)
Protective effects of an oral microencapsulated Mycoplasma hyopneumoniae vaccine against experimental infection in pigs.
C. Weng (1992)
Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid vaccine encapsulated in polymeric microspheres.
C. Yan (1996)
Confocal analysis of fluorescent bead uptake by mouse Peyer's patch follicle‐associated M cells
C. Porta (1992)
Oral immunization with a model protein entrapped in microspheres prepared from derivatized alpha-amino acids.
S. Haas (1996)
Local antibody response to poliovaccine in the human female genital tract.
P. Ogra (1973)
Vaginal immunization of rats with a synthetic peptide from human immunodeficiency virus envelope glycoprotein.
D. O'hagan (1992)
Large porous particles for pulmonary drug delivery.
D. Edwards (1997)
Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat
P. U. Jani (1992)
Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina.
C. Bergquist (1997)
Biologically erodable microspheres as potential oral drug delivery systems
E. Mathiowitz (1997)
Comparative analysis of oral delivery systems for live rotavirus vaccines
J. Duncan (1996)
Peroral immunization of rats with Escherichia coli heat-labile enterotoxin delivered by microspheres.
F. Klipstein (1983)
Evidence for the phagocytic transport of intestinal particles in dogs and rats.
C. Wells (1988)
Intestinal barrier to large particulates in mice.
M. Lefevre (1980)
New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier
C. Damgé (1988)
Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles.
S. Challacombe (1997)
Microparticles as potentially orally active immunological adjuvants.
D. O'hagan (1989)
The adjuvant action of latex particulate carriers.
S. D. Litwin (1965)
Effectiveness of an oral enteric coated vibrio vaccine for use in salmonid fish.
G. Wong (1992)
Novel polymer‐grafted starch microparticles for mucosal delivery of vaccines
P. Heritage (1996)
Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres.
Y. Tabata (1996)
Controlled release microparticles for oral immunization
D. O'hagan (1994)
Immunohistochemical localization of immunoglobulins A, G and M in the mouse female genital tract.
M. Parr (1985)
Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres.
R. Shahin (1995)
Microparticulate absorption from the rat intestine
P. G. Jenkins (1994)
Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.
K. Maloy (1994)
Monoclonal antibody-directed targeting of fluorescent polystyrene microspheres to Peyer's patch M cells.
J. Pappo (1991)
Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles.
P. Maincent (1986)
Specific immune response in humans following rectal delivery of live typhoid vaccine.
B. Forrest (1990)
The role of nasopharyngeal lymphoid tissue.
C. Kuper (1992)
Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes.
F. Zhou (1995)
Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces.
B. Haneberg (1994)
Fate of [14C]poly(DL-lactide-co-glycolide) nanoparticles after intravenous and oral administration to mice
A. Ray (1994)
Biodegradable microparticles for oral immunization.
D. O'hagan (1993)
Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.
D. I. Jones (1997)
Oral induction of the secretory antibody response by soluble and particulate antigens.
D. S. Cox (1984)
Biodegradable microparticles as oral vaccines.
D. O'hagan (1995)
Effect on Cerebral Blood Flow of Orally Administered Indomethacin‐loaded Poly(isobutylcyanoacrylate) and Poly(DL‐lactide) Nanocapsules
N. Ammoury (1990)
Co-polymerised peptide particles II: Oral uptake of a novel co-polymeric nanoparticulate delivery system for peptides
A. M. Hillery (1996)
Oral inoculation of mice with low doses of microencapsulated, noninfectious rotavirus induces virus-specific antibodies in gut-associated lymphoid tissue.
C. Khoury (1995)
Aerosolized aqueous suspensions of poly(L-lactic acid) microspheres
L. E. Masinde (1993)
Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy.
A. Litwin (1996)
Intravaginal immunization in sheep using a bioadhesive microsphere antigen delivery system.
D. O'hagan (1993)
Preparation of enteric-coated microspheres of Mycoplasma hyopneumoniae vaccine with cellulose acetate phthalate: (II). Effect of temperature and pH on the stability and release behaviour of microspheres.
S. Lin (1991)
Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.
E. Cahill (1995)
Light microscopical observations on luminally administered dyes, dextrans, nanospheres and microspheres in the pre-epithelial mucus gel layer of the rat distal colon
L. Szentkuti (1997)
Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres.
K. Allaoui-Attarki (1997)
Enhancement of rotavirus immunogenicity by microencapsulation.
P. Offit (1994)
Protection against vaginal SIV transmission with microencapsulated vaccine.
P. Marx (1993)
Oral immunization with an anti–idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection
J. Whittum-Hudson (1996)
Oral Delivery and Fate of Poly(lactic acid) Microsphere‐encapsulated Interferon in Rats
J. Eyles (1997)
Ultrastructural and cytoarchitectural features of lymphoreticular organs in the colon and rectum of adult BALB/c mice.
R. L. Owen (1991)
Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate
A. T. Florence (1995)
Simple rapid method for the preparation of enteric-coated microspheres.
I. Maharaj (1984)
This paper is referenced by
Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses
M. Oyewumi (2010)
Recent Patents on Oral Vaccine Design
S. Mangal (2009)
Comparison of the adjuvanticity of two different delivery systems on the induction of humoral and cellular responses to synthetic peptides
E. Mata (2010)
Effect of nanosilver particles on hatchability of rainbow trout (Oncorhynchus mykiss) egg and survival of the produced larvae
M. Soltani (2011)
V. J. Ahire (2007)
Adjuvanticity Regulation by Biodegradable Polymeric Nano/microparticle Size.
Jilei Jia (2017)
Recent Developments in Nonliving Antigen Delivery Systems
Derek O'hagan (2009)
Effectiveness of engineering the nontypeable Haemophilus influenzae antigen Omp26 as an S-layer fusion in bacterial ghosts as a mucosal vaccine delivery
E. Riedmann (2011)
Overview of vaccinology with special reference to papillomavirus vaccines.
M. Hilleman (2000)
Recent Advances in Vaccine Adjuvants
M. Singh (2004)
Recombinant Protein Subunit Vaccines and Delivery Methods
A. Banga (2005)
Vaccination of mice against intestinal Trichinella spiralis infections by oral administration of antigens microencapsulated in methacrilic acid copolymers.
M. Dea-Ayuela (2006)
Injectable PLGA Systems for Delivery of Vaccine Antigens
Vesna Milacic (2012)
Sistema de administración oral del toxoide tetánico
V. J. Ahire (2007)
Chitosan microspheres as candidate plasmid vaccine carrier for oral immunisation of Japanese flounder (Paralichthys olivaceus).
Jiyuan Tian (2008)
Oral vaccination in man using antigens in particles: current status.
D. Brayden (2001)
Microparticles for Vaccine Delivery
N. Mody (2017)
Polymeric Particulates to Improve Oral Bioavailability of Peptide Drugs
F. Delié (2005)
Developments in Nanoparticle Embedded Biodegradable Polymers for Packaging and Storage of Fruits and Vegetables
R. B. Gautam (2015)
Spray-dried microparticles: a potential vehicle for oral delivery of vaccines
Lipika Chablani (2012)
Bioadhesive delivery systems for mucosal vaccine delivery
B. Baudner (2010)
Alginate microparticles produced by spray-drying for oral insulin delivery
Kristen Bowey (2009)
The immune response and protective efficacy of vaccination with oral microparticle Aeromonas sobria vaccine in mice.
H. Sun (2007)
Enteric-coated pellets of F4 fimbriae for oral vaccination of suckling piglets against enterotoxigenic Escherichia coli infections.
V. Snoeck (2003)
Cross-Reactivity of Schistosoma mansoni Cytosolic Superoxide Dismutase, a Protective Vaccine Candidate, with Host Superoxide Dismutase and Identification of Parasite-Specific B Epitopes
C. Carvalho-Queiroz (2004)
Surface Mmodification of Poly(DL-lactide-co-glycolide) Nanoparticle
Yu-Mi Oh (2003)
Microparticles as vaccine delivery systems
D. O'hagan (2006)
Polymerised liposomes as intranasal vaccine adjuvants.
Patel Bp (2004)
Semi-IPN chitosan/polyvinylpyrrolidone microspheres and films: sustained release and property optimisation
Taylan Ozerkan (2013)
Degradable polymer microspheres for controlled drug delivery
U. Edlund (2002)
Design of nanoparticle-based dry powder pulmonary vaccines
B. Pulliam (2007)
Engineered Commensal Bacteria as Delivery Systems of Anti-infective Mucosal Protectants
W. Magliani (2002)See more